Glypican 2

Function

Cerebroglycan is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons.[7] Cerebroglycan has especially high affinity for laminin-1.[8]

Implications in cancer

GPC2 has been suggested as a therapeutic target in neuroblastoma.[9][10] GPC2 is highly expressed in about half of neuroblastoma cases and that high GPC2 expression correlates with poor overall survival.[9] GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis.[9] Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models.[9] A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.[10]

gollark: I mean making good use of the DNS packets, not CPU use on each end; I don't really care about that.
gollark: So you probably need checksums now and you use up even more of the packet size.
gollark: And you also need to be able to autodetect properties of the system of DNS servers between you and the authoritative one doing the actual bridging. But that might randomly change (e.g. if you switch network) and start messing up your data.
gollark: But you also want to be able to send data up efficiently, but you're probably using much of the limited space for user data which won't get munged by recursive DNS/proxies/whatever on the session token and whatever, so now you have to deal with *that*.
gollark: Possibly? You apply somewhere.

See also

References
  1. GRCh38: Ensembl release 89: ENSG00000213420 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000029510 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Stipp CS, Litwack ED, Lander AD (January 1994). "Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation". The Journal of Cell Biology. 124 (1–2): 149–60. doi:10.1083/jcb.124.1.149. PMC 2119891. PMID 8294498.
  6. "Entrez Gene: GPC2 glypican 2".
  7. Ivins JK, Litwack ED, Kumbasar A, Stipp CS, Lander AD (April 1997). "Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones" (PDF). Developmental Biology. 184 (2): 320–32. doi:10.1006/dbio.1997.8532. PMID 9133438.
  8. Herndon ME, Stipp CS, Lander AD (February 1999). "Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding". Glycobiology. 9 (2): 143–55. doi:10.1093/glycob/9.2.143. PMID 9949192.
  9. Li N, Fu H, Hewitt SM, Dimitrov DS, Ho M (August 2017). "Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma". Proceedings of the National Academy of Sciences of the United States of America. 114 (32): E6623–E6631. doi:10.1073/pnas.1706055114. PMC 5559039. PMID 28739923.
  10. Bosse KR, Raman P, Zhu Z, Lane M, Martinez D, Heitzeneder S, et al. (September 2017). "Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma". Cancer Cell. 32 (3): 295–309.e12. doi:10.1016/j.ccell.2017.08.003. PMC 5600520. PMID 28898695.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.